Small Cell Lung Cancer Patient Group Features Amgen Head of US Oncology Medical Affairs

(May 28, 2024) The June meeting of the LiveLung Virtual Small Cell Lung Cancer group will feature Vice President, Head of Amgen’s US Oncology Medical Affairs team, Byeong Yoon, PhD, who will discuss a new treatment option for Extensive Stage-Small Cell Lung Cancer (ES-SCLC).

This free, virtual meeting is open to all Small Cell Lung Cancer patients, survivors, and their care partners. The meeting will be held at 12:00 pm ET, Tuesday, June 18, 2024.

Byeong Yoon, PhD is Vice President, Head of Amgen’s US Oncology Medical Affairs team. In his role, Byeong oversees his team to lead the US medical affairs strategy and activities for Amgen’s oncology portfolio. He has held multiple leadership positions within Global and US Medical affairs over the past 15 years, and has been in the pharmaceutical industry for almost 20 years. During that time, he’s had the privilege of working on a number of therapies in oncology, inflammatory, and cardiovascular diseases, including helping bring new therapies to patients suffering from these diseases.
“We are excited to hear Dr. Yoon share more about this new treatment,” says Dusty Donaldson, LiveLung founder, lung cancer survivor and patient advocate. “This new treatment option for Small Cell Lung Cancer may very well be the most impactful advancement in decades for patients diagnosed with this challenging disease.”
Small Cell Lung Cancer patients and their care partners are welcome to RSVP at
https://livelung.link/sclc/0624p. Please register 24 hours before the meeting.

About LiveLung
LiveLung is a 501(c)(3) nonprofit on a mission to improve health outcomes by advancing lung cancer education, early detection, and compassion for people impacted by lung cancer. We do this by hosting a network of monthly educational community lung cancer patient groups. We provide resource bags to dozens of cancer centers where nurse navigators give them to newly diagnosed lung cancer patients.